Connect with us


Pandemic’s ‘acute phase’ may end mid-year – WHO



WORLD Health Organisation director-general, Tedros Ghebreyesus, has stated that boosting vaccination rates is critical to ending COVID-19 outbreak.

  Ghebreyesus made this disclosure during a visit to Afrigen Biologics and Vaccines, which has produced the first mRNA COVID vaccine made in Africa using Moderna’s sequence.

  According to him, the acute phase of the pandemic could end this year, if about 70 per cent of the world’s population is vaccinated.

  “Our expectation is that the acute phase of this pandemic will end this year, of course with one condition, the 70 per cent vaccination (target is achieved) by mid this year around June, Ghebreyesus, told reporters in South Africa.

  “If that is to be done, the acute phase can really end, and that is what we are expecting. It’s in our hands. It’s not a matter of chance. It’s a matter of choice.”

  “We expect this vaccine to be more suited to the contexts in which it will be used, with fewer storage constraints and at a lower price,” Dr Tedros said.

  The vaccine will be ready for clinical trials in November, with approval expected in 2024.

Afrigen is leading the pilot project, backed by the WHO and the Covax initiative.

  Set up in July, the tech transfer hub will train other countries and hand out production licences to poor nations left out in the race for the life-saving shots.

  Dr Tedros said WHO was “committed to supporting the development of local manufacturing in Africa and around the world, to increase regional health security”.

  Just over 11 per cent of Africans are vaccinated, the lowest rate in the world. Last week the WHO’s Africa office said the continent must boost its vaccination rate “six times” to reach the 70 per cent target.

  The world panicked late last year following the outbreak of the highly contagious Omicron variant which led at its peak to four times more daily infections than previous waves.

  Meryame Kitir, Belgium’s Minister of Development Co-operation, who was part of the team visiting the Cape Town, bemoaned the slow progress in talks seeking a waiver on vaccine patents.

  “Vaccines should be a public good, but after two years in the pandemic … we are not a step ahead,” in patent negotiations, she said.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published.


Top Posts